See Medical Affairs. See T1D.
Closing the gap between access to and adoption of type 1 diabetes therapies is a mission priority. Chris Dunn represents these efforts in action.
See our advocates. See T1D.
Through grassroots support, Breakthrough T1D advocates help advance treatments, influence policy, and improve global access to care.
Cardiovascular disease and T1D: Advancing breakthroughs in Europe and beyond
What’s happening? Today, Breakthrough T1D co-hosted an event with leading international diabetes organizations to discuss cardiovascular disease (CVD) and type 1 diabetes (T1D)—where we are, challenges that remain, and how we can work together in Europe and beyond to address this need for the T1D community. The focus of the event: Doing more for CVD […]
Demystifying the pipeline of T1D therapies and devices: Turning ideas into reality
What is the pipeline? Every new medical device, therapy, treatment, and drug—including those for type 1 diabetes (T1D)—goes through the drug development pipeline. Getting a new therapy or device from the earliest stages of research eventually into the hands of people with T1D is a complicated process. Science takes time (from years to decades!), money […]
See our cures research. See T1D.
There are three ways we can get to cures for type 1 diabetes faster: cell therapies, early detection, and disease-modifying therapies.
See our community. See T1D.
Building awareness and understanding about T1D is more important than ever. Together, our stories change how people see T1D.
Two truths and a lie: Separate T1D facts from fiction
There are a lot of commonly believed myths about type 1 diabetes (T1D). Play our game to separate fact from fiction.
The Nobel Prize goes to… Immunologists (with a Breakthrough T1D connection!)
The Nobel Prize in Physiology or Medicine went to three immunologists, including one, Fred Ramsdell, who founded a T1D Fund company.
Why We Walk: Campi Dental
Campi Dental is staying true to its mission of community support by joining their local Breakthrough T1D Walk for the first time this year.
Barbie with type 1 diabetes: Changing the narrative
In December 2023, Mattel approached Breakthrough T1D with a partnership opportunity for the first Barbie with type 1 diabetes (T1D). Less than two years later, in July 2025, Barbie with T1D was launched. The collaboration reflects our commitment to ensuring that the millions of people living with T1D are seen, heard, and empowered. Barbie with […]